Table 4. Performance characteristics of the 4Kscore in predicting GG ≥2 prostate cancer by population and biopsy status.
4Kscore studies | Population | Bx Status | N | GG ≥2 (%) | Cutoff value (%) | Sn (%) | Sp (%) | Bx avoided (%) | Unnecessary Bx avoided (%) |
GG ≥2 missed (%) | Model Used |
---|---|---|---|---|---|---|---|---|---|---|---|
Parekh et al., 2015 (47) | Overall BxRef | Mixed (20% RBx) | 1,012 | 23 | 6 | 94* | 39* | 30 | 39* | 5.6* | Full 4K model |
9 | 90* | 56* | 43 | 56* | 10* | ||||||
12 | 86* | 67* | 51 | 67* | 14* | ||||||
15 | 79* | 76* | 58 | 76* | 21* | ||||||
Zappala et al., 2017 (52) | Overall BxRef | Mixed (20% RBx) | 1,012 | 23 | 7.5 | 93* | 47* | 36 | 47* | 7.4* | Full 4K model |
7.5 | 93* | 46* | 36 | 46* | 6.9* | 4K model without DRE | |||||
Punnen et al., 2018 (49) | Overall BxRef | Mixed (20% RBx) | 366 | 36 | 6 | 99* | 27* | 17 | 27* | 1.5 | Full 4K model |
7.5 | 97* | 34* | 22 | 34* | 3 | ||||||
9 | 96* | 39* | 25 | 39* | 4 | ||||||
12 | 92* | 49* | 31 | 49* | 8 | ||||||
15 | 87* | 57* | 37 | 57* | 13 | ||||||
Bryant et al., 2015 (53) | Overall BxRef | Mixed | 4,765 | 13.3 | 4 | 96* | 31* | 27 | 31* | 4.5* | 4K panel and age |
6 | 90* | 49* | 43 | 49* | 11* | ||||||
8 | 83* | 64* | 56 | 64* | 17* | ||||||
10 | 77* | 74* | 64 | 74* | 23* | ||||||
Braun et al., 2016 (48) | Overall BxRef | Unknown | 749 | 21 | 4 | 99* | 11* | 8.7 | 11* | 1.4* | 4K panel and age |
6 | 96* | 21* | 17 | 21* | 3.8* | ||||||
8 | 94* | 30* | 24 | 30* | 6.3* | ||||||
10 | 92* | 39* | 31 | 39* | 7.7* | ||||||
12 | 89* | 48* | 38 | 48* | 12* | ||||||
Wysock et al., 2020 (51) | Overall BxRef | Unknown | 50 | 44 | 7.5 | 96 | 32 | – | 32* | 4.5* | Full 4K model |
12 | 90 | 54 | – | 54* | 9.9* | ||||||
Nordström et al., 2015 (37) | PSA 3-15 | Bx-naive | 531 | 25 | 10 | 90* | 40* | 30 | 40* | 11 | 4K panel and age |
15 | 78* | 61* | 45 | 61* | 22 | ||||||
20 | 64* | 77* | 56 | 77* | 37 |
Bx, biopsy; Overall BxRef, Overall biopsy referral; RBx, repeat biopsy; 4K panel, PSA, fPSA, iPSA, and hK2; Full 4K model, 4K panel, age, prior biopsy status, and DRE; Sn, sensitivity; Sp, specificity; PSA, ng/mL. Calculated values are labeled with an asterisk (*).